Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) FCF Margin (2016 - 2025)

Marimed (MRMD) has disclosed FCF Margin for 13 consecutive years, with 5.21% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin rose 956.0% to 5.21% in Q3 2025 year-over-year; TTM through Sep 2025 was 1.06%, a 421.0% decrease, with the full-year FY2024 number at 3.28%, down 726.0% from a year prior.
  • FCF Margin was 5.21% for Q3 2025 at Marimed, up from 0.03% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 33.02% in Q3 2022 to a low of 30.62% in Q2 2022.
  • A 5-year average of 2.96% and a median of 2.71% in 2025 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: crashed -4315bps in 2022, then soared 5994bps in 2023.
  • Marimed's FCF Margin stood at 14.12% in 2021, then tumbled by -306bps to 29.03% in 2022, then skyrocketed by 206bps to 30.91% in 2023, then plummeted by -112bps to 3.77% in 2024, then skyrocketed by 238bps to 5.21% in 2025.
  • Per Business Quant, the three most recent readings for MRMD's FCF Margin are 5.21% (Q3 2025), 0.03% (Q2 2025), and 2.71% (Q1 2025).